Drug Profile
Research programme: neurodegenerative and age-related disorders therapeutics - Alkahest
Alternative Names: Age-related diseases therapeutics - Alkahest; Neurodegenerative disorders therapeutics - AlkahestLatest Information Update: 28 Feb 2022
Price :
$50
*
At a glance
- Originator Alkahest
- Class Antidementias; Antiparkinsonians; Recombinant proteins; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cognition disorders; Neurodegenerative disorders
Most Recent Events
- 28 Feb 2022 No recent reports of development identified for preclinical development in Cognition-disorders in USA
- 28 Feb 2022 No recent reports of development identified for preclinical development in Neurodegenerative-disorders in USA
- 23 Jan 2018 Preclinical trials in Neurodegenerative disorders in USA (unspecified route)